42
NEC Nawaf Al-Dajani

NEC

  • Upload
    gotzon

  • View
    33

  • Download
    0

Embed Size (px)

DESCRIPTION

NEC. Nawaf Al-Dajani. Disclosure. NEC. Definition Early history Epidemiology Pathophysiology Presentation Prevention Treatment. Definition. Acute inflammatory disease process affecting GI tract of neonates. Usually ass’ necrosis of affected part. Unpredictable course. History. - PowerPoint PPT Presentation

Citation preview

Page 1: NEC

NECNEC

Nawaf Al-DajaniNawaf Al-Dajani

Page 2: NEC

Disclosure Disclosure

Page 3: NEC

NECNEC Definition Early history Epidemiology Pathophysiology Presentation Prevention Treatment

Definition Early history Epidemiology Pathophysiology Presentation Prevention Treatment

Page 4: NEC

Definition Definition

Acute inflammatory disease process affecting GI tract of neonates.

Usually ass’ necrosis of affected part.

Unpredictable course.

Acute inflammatory disease process affecting GI tract of neonates.

Usually ass’ necrosis of affected part.

Unpredictable course.

Page 5: NEC

History History

Not known prior 1950’s First described by Schmid &

Quaiser. Well recognized entity 1960-1970. High MR Idiopathic GI perforations.

Not known prior 1950’s First described by Schmid &

Quaiser. Well recognized entity 1960-1970. High MR Idiopathic GI perforations.

Page 6: NEC

Epidemiology Epidemiology Affect 1-5% all NICU admissions. Up to 10% of prem. less than 1.5 kg. 10% occur in term neonates M=F Black > Onset inversely related to GA. 10* in infant who have been fed. Clusters may occur.

Affect 1-5% all NICU admissions. Up to 10% of prem. less than 1.5 kg. 10% occur in term neonates M=F Black > Onset inversely related to GA. 10* in infant who have been fed. Clusters may occur.

Page 7: NEC

Pathophysiology Pathophysiology

Page 8: NEC

NECROTIZING ENTEROCOLITISNECROTIZING

ENTEROCOLITIS Pathophysiology:

Pathophysiology:

UNKNOWN CAUSE…….

Page 9: NEC

Preemies gut is differentPreemies gut is different

Inadequate IgAScanty T lymphocytesLack of adequate antibody responseHigher membrane permeabilityLower motility and emptyingMucin blanket Tight junction are deficient

Page 10: NEC

PRIMARY INFECTIOUS AGENTS

Bacteria, Bacterial toxin, Fungus

CIRCULATORY INSTABILITY

Hypoxic-ischemic event Polycythemia

MUCOSAL INJURY

ENTERAL FEEDINGS

Hypertonic formula or medication, H2 gas production,

Endotoxin production

INFLAMMATORY MEDIATORS

Inflammatory cells (macrophage) Platelet activating factor (PAF) Tumor necrosis factor (TNF) Leukotriene C4, Interleukin 1; 6

Page 11: NEC

Preemies gut Preemies gut

PMNM0

Immune cellsPAFTNF

Luminal flow

Mucin Inflammation

VasoconstrictionTissue permeability

Page 12: NEC

Risk factorsRisk factors

IUGR RDS Cyanotic heart disease Blood Tx Gastroschisis

IUGR RDS Cyanotic heart disease Blood Tx Gastroschisis

Page 13: NEC

Temperature instabilityApneaEpisodes of Bradycardias & DesaturationLethargyAcidosisThrombocytopenia Shock

Feeding intoleranceIncreased gastric residualsAbdominal distentionOccult blood/ HematocheziaPeritonitisDiscoloration of abdominal wallAbdominal mass

Presentation

Page 14: NEC

Bell’s Stages

I. Suspected diseaseMild systemic signs (apnea, bradycardia, temperature instability)Mild intestinal signs (abdominal distention, gastric residuals, bloody stools)Nonspecific or normal radiological signs

II. Definite diseaseMild to moderate systemic illnessAdditional intestinal signs (absent bowel sounds, abdominal tenderness)Specific radiologic signs (pneumatosis intestinalis or portal venous air)Laboratory changes (metabolic acidosis, thrombocytopenia)

III. Advanced diseaseSevere systemic illness (hypotension)Additional intestinal signs (marked abdominal distention, peritonitis)Severe radiologic signs (pneumoperitoneum)Additional laboratory changes (metabolic and respiratory acidosis, DIC)

Page 15: NEC

Radiographs Radiographs

Page 16: NEC
Page 17: NEC
Page 18: NEC
Page 19: NEC
Page 20: NEC

Management “same same” Management “same same” Medical emergency: Cardiorespiratory support: Ventilation “avoid CPAP” Fluid +/- inotrops Invasive monitoring Maintain Sat. higher than acceptable for

GA. NPO, NG (IMS)

Medical emergency: Cardiorespiratory support: Ventilation “avoid CPAP” Fluid +/- inotrops Invasive monitoring Maintain Sat. higher than acceptable for

GA. NPO, NG (IMS)

Page 21: NEC

CBC Coags Lytes & BG SWU Antibiotics Maintain Hg > 12 Maintain BS

CBC Coags Lytes & BG SWU Antibiotics Maintain Hg > 12 Maintain BS

Page 22: NEC

Strict ins/out Surgical referral Serial X-ray is not advisable routinely Have a wise mind & strong arms to

push the surgeons when approriate Be aggressive when u have to B Optimize nutritional support

Strict ins/out Surgical referral Serial X-ray is not advisable routinely Have a wise mind & strong arms to

push the surgeons when approriate Be aggressive when u have to B Optimize nutritional support

Page 23: NEC

Closely follow hg/plt/BG May need to use diuretics early Serial clinical assessment Follow SWU Watch for opportunistic infections Counsel the family about prognosis

Closely follow hg/plt/BG May need to use diuretics early Serial clinical assessment Follow SWU Watch for opportunistic infections Counsel the family about prognosis

Page 24: NEC

Surgical approach???Surgical approach???

Free air remain the strongest indication??

Newer trend to use peritoneal drain initially!!

Free air remain the strongest indication??

Newer trend to use peritoneal drain initially!!Moss et al NEJM,2006

Rees et al, Ann Surg,2008

Emil et al, Eurp J Surg, 2008

Page 25: NEC

Complication Complication

Death 20-40% (early/late) Bleeding Stricture Short bowel syndrome (27%) Abscess Neurodevelopmental delay

Death 20-40% (early/late) Bleeding Stricture Short bowel syndrome (27%) Abscess Neurodevelopmental delay

Page 26: NEC

Breast Milk

Immuno-globulin

Antibiotics

Probiotics

Slow feeding

StandardizedFeedingprotocols

PreventionOf NEC

Page 27: NEC

Prevention Prevention

Breast milk: Most “only” known safe preventive

measure. 926 pts in prospective study. 6-10* risk of NEC in formula vs BM 3 times if formula + BM

Breast milk: Most “only” known safe preventive

measure. 926 pts in prospective study. 6-10* risk of NEC in formula vs BM 3 times if formula + BM

Lucas & Cole, Lancet, 1990Schanler, 1999McGuire, 2003

Page 28: NEC

Contin…Contin… Feeding strategies: One large trial showed benefit of slow

rate @ 20 cc/kg/d, stopped early.

Many other trials & meta-analyses; showed no difference

Kennedy,2003 Kamitsuka, 2000

Feeding strategies: One large trial showed benefit of slow

rate @ 20 cc/kg/d, stopped early.

Many other trials & meta-analyses; showed no difference

Kennedy,2003 Kamitsuka, 2000

Berseth et al, 2003

Page 29: NEC

Feeding protocol: Modest evidence that protocol for

feeding may reduce the risk of NEC

Trophic feeds:

Feeding protocol: Modest evidence that protocol for

feeding may reduce the risk of NEC

Trophic feeds:

Schurr & Perkins, Cochrane review

Tyson & Kennedy

Page 30: NEC
Page 31: NEC

Feed #

1 2 3 4 5 6 7 8 9 10 11 12

1 1 1 1 1 1 1 1.5 1.5 1.5 1.5 1.5 1.5

2 2 2 2 2 2 2 2.5 2.5 2.5 2.5 2.5 2.5

Day 3 3 3 3 3 3 3 3.5 3.5 3.5 3.5 3.5 3.5

4 4 4 4 4 4 4 4.5 4.5 4.5 4.5 4.5 4.5

5 5 5 5 5 5 5 5.5 5.5 5.5 6 6 6

6 6 6.5 6.5 6.5 6.5 7 7 7 7 7.5 7.5 7.5

Example of guidelines

Page 32: NEC
Page 33: NEC

Probiotics: for life Dani et al, no difference Other, Lin, Bin-Nun 2 meta-analyses, Al-faleh, Deshpande Showed decrease NEC-II & Mortality Many unanswered Qs?

Probiotics: for life Dani et al, no difference Other, Lin, Bin-Nun 2 meta-analyses, Al-faleh, Deshpande Showed decrease NEC-II & Mortality Many unanswered Qs?

Probiotics

Page 34: NEC

Amino acid supp: Arginine supp, Amin, 2002 Enteral glutamine, Vaughn, 2003

Immunoglobulin: IgG/IgA po, no difference, Foster, 2004 IVIG, Faranoff, 1994

Amino acid supp: Arginine supp, Amin, 2002 Enteral glutamine, Vaughn, 2003

Immunoglobulin: IgG/IgA po, no difference, Foster, 2004 IVIG, Faranoff, 1994

Page 35: NEC

Antibiotics: Oral Gentamicin: Meta-analysis of 5 studies showed

efficacy in reduction of NEC (Bury, 2004)

Erythromycin PO/IV; Ng et al

Antibiotics: Oral Gentamicin: Meta-analysis of 5 studies showed

efficacy in reduction of NEC (Bury, 2004)

Erythromycin PO/IV; Ng et al

Page 36: NEC

H2 hitamine blocker: Usage of H2 blocker ass’ NEC Guillet 2006

• Indomethacin****

H2 hitamine blocker: Usage of H2 blocker ass’ NEC Guillet 2006

• Indomethacin****

Page 37: NEC

Conclusion Conclusion A disease of medical progress Encourage EBM Control multiple pregnancy

“induced” Standardized feeding protocol Probiotics looming around Medical care 1st & scalpel

A disease of medical progress Encourage EBM Control multiple pregnancy

“induced” Standardized feeding protocol Probiotics looming around Medical care 1st & scalpel

Page 38: NEC
Page 39: NEC
Page 40: NEC
Page 41: NEC
Page 42: NEC